Home » Newsletters » BioWorld Science

BioWorld Science

May 29, 2015

View Archived Issues

AQP-4 inhibition improves survival of cardiac allografts in mice

Levetiracetam shows potential for the treatment of PVL

ISTH-0036 shows potential for the treatment of ophthalmic diseases

Daiichi Sankyo presents interaction study results for mirogabalin besylate

biOasis and partners awarded research grant focused on blood-brain barrier

Juno and Editas collaborate on next-generation CAR T and TCR therapies for cancer

Bayer partners with AACR to fund cancer research fellowships

Empagliflozin/metformin pill approved in E.U. for type 2 diabetes

Prevention of liver fibrosis using hydrodynamic gene delivery of MMP13

Pfizer launches grant program to study palbociclib in breast cancer

Seres Therapeutics doses first patient in C. difficile recurrent infection trial of SER-109

Celldex starts phase I/II trial of varlilumab and sunitinib in RCC

XBiotech cleared to start trial of antibody therapy for S.aureus infection

The Scripps Research Institute receives NIH grant to study novel obesity pathway

Merck & Co. files NDA for grazoprevir/elbasvir for HCV infection

IRM reports development of farnesoid X receptor agonists

Purdue Pharma discloses Nav1.7 sodium channel blockers

University of Montpellier and INSERM jointly patent new HER3 antibodies

Chymase inhibitors prepared and tested at Bayer

Merck & Co. synthesizes antidiabetic FFAR1 agonists

Pacira to conduct additional phase III trials to support sNDA for Exparel

Galenica to commercialize Roche's Mircera in U.S.

European Commission approves intermittent use of Esmya for long-term management of uterine fibroids

EMA validates MAA for emtricitabine/tenofovir alafenamide fumarate for HIV

Preliminary phase I data on PDS-0101 in patients with pre-cervical cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...